Opinions of Health Care Providers About Neuromodulation for Pain: Results of an Online Survey at the 2nd Joint Congress of the International Neuromodulation Society European Chapters

Lisa Goudman; Ann De Smedt; Maxime Billot; Manuel Roulaud; Philippe Rigoard; Maarten Moens

doi:10.1016/j.neurom.2022.04.038

Opinions of Health Care Providers About Neuromodulation for Pain: Results of an Online Survey at the 2nd Joint Congress of the International Neuromodulation Society European Chapters

Lisa Goudman, Ann De Smedt, Maxime Billot, Manuel Roulaud, Philippe Rigoard, Maarten Moens

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

62 Downloads (Pure)

Abstract

INTRODUCTION: Neuromodulation for pain has been successfully applied for decades, in that the goals and expectations that patients aim to achieve are clearly described. Nevertheless, the point of view of health care providers is less clear. Therefore, this study aimed to explore the goals, expectations, and definition of success for neuromodulation for pain according to health care providers.

MATERIALS AND METHODS: An online survey was developed and spread at the 2nd Joint Congress of the International Neuromodulation Society (INS) European Chapters in September 2021 in Paris. Respondents were asked 1) to select the goals to treat patients with neuromodulation for pain, 2) to indicate factors that they expect to change according to neuromodulation for pain, and 3) to provide their definition of success of neuromodulation for pain.

RESULTS: We approached 101 respondents, of whom 88 health care providers at least partly completed the survey. Increasing mobility/functionality (26.7%), decreasing pain intensity (24.5%), and decreasing medication use (16.6%) were the most frequently reported goals of neuromodulation. The same top three variables were selected as factors that health care providers expected to change. For the definition of success, quality of life of patients outranked other definitions. Other highly ranked definitions, in descending order, were obtaining pain relief, increasing functionality, and increasing patient satisfaction.

DISCUSSION: Goals and expectations of health care providers are not completely in line with previously explored goals of patients that are related to pain relief and improving walking abilities. Health care providers seem to put a high emphasis on the quality of life of the patient when evaluating the success of neuromodulation, which is not completely aligned with the currently used reimbursement rules that are mainly focusing on pain relief instead of incorporating health-related quality of life.

CLINICAL TRIAL REGISTRATION: The Clinicaltrials.gov registration number for the study is NCT05013840.

Original language	English
Pages (from-to)	1887-1892
Number of pages	6
Journal	Neuromodulation
Volume	26
Issue number	8
DOIs	https://doi.org/10.1016/j.neurom.2022.04.038
Publication status	Published - Dec 2023

Bibliographical note

Funding Information:
Source(s) of financial support: The authors reported no funding sources.

Funding Information:
Source(s) of financial support: The authors reported no funding sources. Conflict of Interest: Lisa Goudman is a postdoctoral research fellow funded by the Research Foundation Flanders, Belgium (project number 12ZF622N). Philippe Rigoard reports grants and consultant fees from Medtronic, Abbott, and Boston Scientific, outside the submitted work. Maarten Moens has received speaker fees from Medtronic and Nevro. STIMULUS received independent research grants from Medtronic. The remaining authors reported no conflict of interest.

Publisher Copyright:
© 2022 International Neuromodulation Society

Keywords

Chronic pain management
clinical success
goal setting
physicians
spinal cord stimulation

Access to Document

10.1016/j.neurom.2022.04.038

84605456Accepted author manuscript, 342 KBLicence: Unspecified

Handle.net

Persistent link

Cite this

@article{937b297214c94ed8a6fad9329fc8137f,

title = "Opinions of Health Care Providers About Neuromodulation for Pain: Results of an Online Survey at the 2nd Joint Congress of the International Neuromodulation Society European Chapters",

abstract = "INTRODUCTION: Neuromodulation for pain has been successfully applied for decades, in that the goals and expectations that patients aim to achieve are clearly described. Nevertheless, the point of view of health care providers is less clear. Therefore, this study aimed to explore the goals, expectations, and definition of success for neuromodulation for pain according to health care providers.MATERIALS AND METHODS: An online survey was developed and spread at the 2nd Joint Congress of the International Neuromodulation Society (INS) European Chapters in September 2021 in Paris. Respondents were asked 1) to select the goals to treat patients with neuromodulation for pain, 2) to indicate factors that they expect to change according to neuromodulation for pain, and 3) to provide their definition of success of neuromodulation for pain.RESULTS: We approached 101 respondents, of whom 88 health care providers at least partly completed the survey. Increasing mobility/functionality (26.7%), decreasing pain intensity (24.5%), and decreasing medication use (16.6%) were the most frequently reported goals of neuromodulation. The same top three variables were selected as factors that health care providers expected to change. For the definition of success, quality of life of patients outranked other definitions. Other highly ranked definitions, in descending order, were obtaining pain relief, increasing functionality, and increasing patient satisfaction.DISCUSSION: Goals and expectations of health care providers are not completely in line with previously explored goals of patients that are related to pain relief and improving walking abilities. Health care providers seem to put a high emphasis on the quality of life of the patient when evaluating the success of neuromodulation, which is not completely aligned with the currently used reimbursement rules that are mainly focusing on pain relief instead of incorporating health-related quality of life.CLINICAL TRIAL REGISTRATION: The Clinicaltrials.gov registration number for the study is NCT05013840.",

keywords = "Chronic pain management, clinical success, goal setting, physicians, spinal cord stimulation",

author = "Lisa Goudman and {De Smedt}, Ann and Maxime Billot and Manuel Roulaud and Philippe Rigoard and Maarten Moens",

note = "Funding Information: Source(s) of financial support: The authors reported no funding sources. Funding Information: Source(s) of financial support: The authors reported no funding sources. Conflict of Interest: Lisa Goudman is a postdoctoral research fellow funded by the Research Foundation Flanders, Belgium (project number 12ZF622N). Philippe Rigoard reports grants and consultant fees from Medtronic, Abbott, and Boston Scientific, outside the submitted work. Maarten Moens has received speaker fees from Medtronic and Nevro. STIMULUS received independent research grants from Medtronic. The remaining authors reported no conflict of interest. Publisher Copyright: {\textcopyright} 2022 International Neuromodulation Society",

year = "2023",

month = dec,

doi = "10.1016/j.neurom.2022.04.038",

language = "English",

volume = "26",

pages = "1887--1892",

journal = "Neuromodulation",

issn = "1094-7159",

publisher = "Wiley-Blackwell",

number = "8",

}

TY - JOUR

T1 - Opinions of Health Care Providers About Neuromodulation for Pain

T2 - Results of an Online Survey at the 2nd Joint Congress of the International Neuromodulation Society European Chapters

AU - Goudman, Lisa

AU - De Smedt, Ann

AU - Billot, Maxime

AU - Roulaud, Manuel

AU - Rigoard, Philippe

AU - Moens, Maarten

N1 - Funding Information: Source(s) of financial support: The authors reported no funding sources. Funding Information: Source(s) of financial support: The authors reported no funding sources. Conflict of Interest: Lisa Goudman is a postdoctoral research fellow funded by the Research Foundation Flanders, Belgium (project number 12ZF622N). Philippe Rigoard reports grants and consultant fees from Medtronic, Abbott, and Boston Scientific, outside the submitted work. Maarten Moens has received speaker fees from Medtronic and Nevro. STIMULUS received independent research grants from Medtronic. The remaining authors reported no conflict of interest. Publisher Copyright: © 2022 International Neuromodulation Society

PY - 2023/12

Y1 - 2023/12

N2 - INTRODUCTION: Neuromodulation for pain has been successfully applied for decades, in that the goals and expectations that patients aim to achieve are clearly described. Nevertheless, the point of view of health care providers is less clear. Therefore, this study aimed to explore the goals, expectations, and definition of success for neuromodulation for pain according to health care providers.MATERIALS AND METHODS: An online survey was developed and spread at the 2nd Joint Congress of the International Neuromodulation Society (INS) European Chapters in September 2021 in Paris. Respondents were asked 1) to select the goals to treat patients with neuromodulation for pain, 2) to indicate factors that they expect to change according to neuromodulation for pain, and 3) to provide their definition of success of neuromodulation for pain.RESULTS: We approached 101 respondents, of whom 88 health care providers at least partly completed the survey. Increasing mobility/functionality (26.7%), decreasing pain intensity (24.5%), and decreasing medication use (16.6%) were the most frequently reported goals of neuromodulation. The same top three variables were selected as factors that health care providers expected to change. For the definition of success, quality of life of patients outranked other definitions. Other highly ranked definitions, in descending order, were obtaining pain relief, increasing functionality, and increasing patient satisfaction.DISCUSSION: Goals and expectations of health care providers are not completely in line with previously explored goals of patients that are related to pain relief and improving walking abilities. Health care providers seem to put a high emphasis on the quality of life of the patient when evaluating the success of neuromodulation, which is not completely aligned with the currently used reimbursement rules that are mainly focusing on pain relief instead of incorporating health-related quality of life.CLINICAL TRIAL REGISTRATION: The Clinicaltrials.gov registration number for the study is NCT05013840.

AB - INTRODUCTION: Neuromodulation for pain has been successfully applied for decades, in that the goals and expectations that patients aim to achieve are clearly described. Nevertheless, the point of view of health care providers is less clear. Therefore, this study aimed to explore the goals, expectations, and definition of success for neuromodulation for pain according to health care providers.MATERIALS AND METHODS: An online survey was developed and spread at the 2nd Joint Congress of the International Neuromodulation Society (INS) European Chapters in September 2021 in Paris. Respondents were asked 1) to select the goals to treat patients with neuromodulation for pain, 2) to indicate factors that they expect to change according to neuromodulation for pain, and 3) to provide their definition of success of neuromodulation for pain.RESULTS: We approached 101 respondents, of whom 88 health care providers at least partly completed the survey. Increasing mobility/functionality (26.7%), decreasing pain intensity (24.5%), and decreasing medication use (16.6%) were the most frequently reported goals of neuromodulation. The same top three variables were selected as factors that health care providers expected to change. For the definition of success, quality of life of patients outranked other definitions. Other highly ranked definitions, in descending order, were obtaining pain relief, increasing functionality, and increasing patient satisfaction.DISCUSSION: Goals and expectations of health care providers are not completely in line with previously explored goals of patients that are related to pain relief and improving walking abilities. Health care providers seem to put a high emphasis on the quality of life of the patient when evaluating the success of neuromodulation, which is not completely aligned with the currently used reimbursement rules that are mainly focusing on pain relief instead of incorporating health-related quality of life.CLINICAL TRIAL REGISTRATION: The Clinicaltrials.gov registration number for the study is NCT05013840.

KW - Chronic pain management

KW - clinical success

KW - goal setting

KW - physicians

KW - spinal cord stimulation

UR - http://www.scopus.com/inward/record.url?scp=85132657205&partnerID=8YFLogxK

U2 - 10.1016/j.neurom.2022.04.038

DO - 10.1016/j.neurom.2022.04.038

M3 - Article

C2 - 35551866

SN - 1094-7159

VL - 26

SP - 1887

EP - 1892

JO - Neuromodulation

JF - Neuromodulation

IS - 8

ER -

Opinions of Health Care Providers About Neuromodulation for Pain: Results of an Online Survey at the 2nd Joint Congress of the International Neuromodulation Society European Chapters

Abstract

Bibliographical note

Keywords

Access to Document

Handle.net

Other files and links

Fingerprint

Cite this